As the FDA moves to speed early-stage clinical trials, former commissioners split on whether the public will see a reform or ...
Third positive data readout for the extended-release minoxidil positions drug for filing in male pattern hair loss, with ...
What's happening, why it matters and what's next at FDA. This edition explores the agency's approval of Alcon's Brytly ...
Office of Dietary Supplement Programs announces availability of “New Dietary Ingredient (NDI) Notifications and Related ...
AdvaMed CEO Scott Whitaker listed tariffs, user fees, reimbursement predictability and strengthening cybersecurity as his top ...
Fractyl’s Revita met the six-month co-primary endpoint in the 308-patient REMAIN-1 pivotal study, and a De Novo request is ...
Dr. Squatch’s proposed $9m settlement over ‘natural’ claims and Sol de Janeiro’s trade dress dispute with MCoBeauty offer two ...
Chief global commercialization officer Anthony Mancini talked to Scrip about why the company is building a commercial ...
Proposals for a regulatory sandbox system in Brazil were informed by experiences in other countries, and a pilot involving ...
Medicines For Europe has suggested that the Netherlands’ proposal to transpose the Urban Waste Water Treatment Directive ...
The UK agency confirms an AI center, early access scheme and PCCPs in a push for more adaptive regulation – but industry ...
Among other executive moves are two Roche departures, to Oak Hill Bio and Pharmanovia, and three Moderna departures, to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results